For years, Chinese language corporations equivalent to Alibaba and Baidu headed to the U.S. to record their shares, citing its deeper capital markets and better valuations. Now, one American biotech agency is betting on doing the other. Axiom Biosciences, a San Diego-based developer of regenerative and genetic medicines, plans to go public in Hong Kong... Read More


:max_bytes(150000):strip_icc():format(jpeg)/Health-GettyImages-1440005476-c63e5435f2e04158a151af266c47e508.jpg?w=600&resize=600,400&ssl=1)









:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)




Recent Comments